Literature DB >> 8381185

Nonsteroidal inhibitors of human type I steroid 5-alpha-reductase.

C D Jones1, J E Audia, D E Lawhorn, L A McQuaid, B L Neubauer, A J Pike, P A Pennington, N B Stamm, R E Toomey, K S Hirsch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8381185     DOI： 10.1021/jm00055a014

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  5 in total

Review 1.  Clinical application of 5alpha-reductase inhibitors.

Authors:  A Cilotti; G Danza; M Serio
Journal:  J Endocrinol Invest       Date:  2001-03       Impact factor: 4.256

Review 2.  Targeting cancer using cholesterol conjugates.

Authors:  Awwad A Radwan; Fares K Alanazi
Journal:  Saudi Pharm J       Date:  2013-01-31       Impact factor: 4.330

3.  Lithium Perchlorate-, Acetic Anhydride-, and Triphenylphosphine-assisted Multicomponent Syntheses of 4-Unsubstituted 2,5-Dioxooctahydroquinoline-3-carboxylates and 3-carbonitriles.

Authors:  Xingxian Gu; Gunda I Georg
Journal:  Tetrahedron       Date:  2013-09-05       Impact factor: 2.457

4.  Synthesis and 5α-reductase inhibitory activity of C₂₁ steroids having 1,4-diene or 4,6-diene 20-ones and 4-azasteroid 20-oximes.

Authors:  Sujeong Kim; Yong-ung Kim; Eunsook Ma
Journal:  Molecules       Date:  2011-12-30       Impact factor: 4.411

5.  Synthesis of pregnane derivatives, their cytotoxicity on LNCap and PC-3 cells, and screening on 5alpha-reductase inhibitory activity.

Authors:  Sujeong Kim; Eunsook Ma
Journal:  Molecules       Date:  2009-11-17       Impact factor: 4.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.